Kurtti, Amanda <br/><br/>
Obesity is not strongly associated with increased risk for febrile neutropenia during levofloxacin prophylaxis in patients with hematological malignancies receiving intermediate-risk myelosuppressive chemotherapy.  [electronic resource] 

 -  Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners  Sep 2020 
 - 1301-1305 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1477-092X 
<br/><br/><label>Standard No.: </label>10.1177/1078155219890403  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Anti-Bacterial Agents--therapeutic use<br/>Antibiotic Prophylaxis--trends<br/>Antineoplastic Agents--adverse effects<br/>Body Mass Index<br/>Cohort Studies<br/>Febrile Neutropenia--chemically induced<br/>Female<br/>Hematologic Neoplasms--drug therapy<br/>Humans<br/>Levofloxacin--therapeutic use<br/>Male<br/>Middle Aged<br/>Obesity--drug therapy<br/>Retrospective Studies<br/>Risk Factors